Related Experiment Video
Updated: Jul 3, 2026
A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Should you screen--or not? The latest recommendations
1Department of Family and Community Medicine, University of Arizona College of Medicine, Phoenix, AZ, USA. dougco@u.arizona.edu
Insights
The Task Force updated screening guidelines, lowering the age for Chlamydia screening and advising against NSAIDs for colorectal cancer prevention. New recommendations address drinking and driving counseling and illicit drug use screening.
Area of Science:
- Preventive Medicine
- Public Health Guidelines
- Clinical Recommendations
Background:
- The Task Force regularly reviews and updates evidence-based clinical preventive service recommendations.
- Previous guidelines covered a range of screenings and counseling, with periodic revisions based on new research.
Purpose of the Study:
- To communicate recent changes and new recommendations issued by the Task Force.
- To inform healthcare providers and the public about updated guidelines on various health screenings and preventive measures.
Main Methods:
- Review of recent Task Force publications and guideline updates.
- Analysis of changes in recommendations regarding specific conditions and behaviors.
Main Results:
- Chlamydia screening age for sexually active women reduced to 24 years and younger.
- Recommendation against aspirin or NSAIDs for colorectal cancer prevention.
- Updated stance on carotid artery stenosis screening and new recommendations for drinking and driving counseling and illicit drug use screening, with insufficient evidence cited.
Conclusions:
- The Task Force has implemented several key changes to its recommendations for preventive health services.
- These updates reflect evolving scientific evidence and aim to optimize public health outcomes.
Abstract:
Last year, and in the early part of this year, the Task Force issued a number of recommendations on topics ranging from hypertension screening to screening for illicit drug use. While some of these recommendations were reaffirmations of past recommendations, others included some changes. The Task Force has: 1) dropped the age for routine screening for Chlamydia in sexually active women from 25 years and younger to 24 and younger; 2) added a recommendation against the use of aspirin or other nonsteroidal anti-inflammatory drugs (NSAIDs) to prevent colorectal cancer (CRC); 3) changed its recommendation on screening for carotid artery stenosis. In 1996, the Task Force noted that the evidence was insufficient to make a recommendation; in 2007 it recommended against such routine screening; 4) added recommendations on counseling patients about drinking and driving, as well as on screening for illicit drug use. In both cases, the Task Force says the evidence is insufficient to recommend for or against.
Related Concept Videos
02:46Genetic Screens
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
01:30Preventive Healthcare Services
01:25Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT